
Pasirinkite etiketę
rodoma tiesiai ant flakonoLaboratorijos ataskaita
PDF- Ištirta
- BPC + TB Blend 10mg (5+5)
- Laboratorija
- Analiza Białek
- Data
- October 2026
- Rezultatas
- 99% purity (BPC-157 5.47 mg + TB-500 5.29 mg)
- Endotoksinai
- 6.00 EU/vial
- Užsakymo nr.
- Slaptažodis
Ištirta nepriklausomai, su slaptažodžiu galima patikrinti tiesiogiai laboratorijoje.
BPC + TB Blend
Healing
- Patikrinta laboratorijoje · 99% grynumas
- Siunčiame iš Vokietijos
Užsakymas
- DHL su sekimu
- Diskreti pakuotė
Trumpai
BPC + TB Blend skaičiais
Pagrindiniai rodikliai iš mūsų žinyno.
Visas žinyno įrašas- Class
- Healing blendBPC-157 + TB-500
- Use
- Subcutaneousin mg, half/half
- Sizes
- 10 to 30 mg3 sizes in the shop
What studies show
The source in the lexicon- Crockford et al., Annals of the New York Academy of Sciences, 2010
Žinios
Viskas apie BPC + TB Blend
Išsami informacija netrukus.
Dozavimas
Įkeliama dozavimo informacija …
Pravers
Ko dar jums reikės
Bakteriostatinis vanduo į krepšelį pridedamas automatiškai. Švirkštai ir servetėlės - vienu paspaudimu.
Insulino švirkštai
10 vnt. · 5.50 €
Spiritinės servetėlės
50 vnt. · 10 €
Kiek vandens?
Vienetai ant švirkšto jūsų flakono dydžiui.
Atidaryti skaičiuoklę →Are there studies on the ready-made blend?
No. As of 26 October 2026 there is no trial with BPC-157 and TB-500 together on ClinicalTrials.gov. PubMed has one rat study on the Achilles tendon and three case reports on jaw nerve damage in which several peptides and other agents were given together. Cause and effect cannot be derived from them.
Do both work better together?
That is not established. In 32 rats with a repaired Achilles tendon each on its own was linked to better tendon tissue, significantly above all with TB-500, which also raised tensile strength. The combination gave no advantage over either alone. The authors suspect that both feed into the same signalling pathways.
What is TB-500?
TB-500 is sold as a fragment of thymosin beta-4. Thymosin beta-4 is the main peptide that binds free actin in cells and is linked to cell migration, new vessel formation and tissue repair. A 2026 review finds hardly any solid human safety data for TB-500.
How are the two components thought to work?
BPC-157 raised the receptor VEGFR2 and new vessel formation in vessel cells. Thymosin beta-4 carries its vessel-forming effect in its actin-binding motif and sped up wound healing in rats. Both come from cell and animal experiments.
Which trials exist on the components?
Thymosin beta-4 was given into a vein in phase 2 after heart attack and tested earlier as a gel for pressure and leg ulcers, a third heart trial has been announced. For BPC-157 a phase 1 trial after shoulder surgery is planned, a study with gummies was completed without results.
Which side effects are known?
None for the blend. No treatment-related side effects occurred in the three small human studies on BPC-157, but the certainty is very low. 40 healthy people tolerated thymosin beta-4 into a vein without serious side effects. One review warns of risks from unregulated manufacturing.
Susiję
Susiję produktai
BPC-157
Peptidai · Gijimas ir atsistatymas Gijimas ir atsistatymas
Dydžių: 4
Patikrinta laboratorijoje
= nuo 5.2 €/flakonas
TB-500 (Thymosin B4)
Peptidai · Gijimas ir atsistatymas Gijimas ir atsistatymas
Dydžių: 3
Patikrinta laboratorijoje
= nuo 18.8 €/flakonas
TB-500 FRAG
Peptidai · Gijimas ir atsistatymas Gijimas ir atsistatymas
1 dydis
= 24.8 €/flakonas
BPC + TB + KPV Blend
Peptidai · Gijimas ir atsistatymas Gijimas ir atsistatymas
1 dydis
= 52 €/flakonas
BPC + TB Blend